SOLID NEOPLASMS WITH NTRK FUSIONS

Clinical trials for SOLID NEOPLASMS WITH NTRK FUSIONS explained in plain language.

Never miss a new study

Get alerted when new SOLID NEOPLASMS WITH NTRK FUSIONS trials appear

Sign up with your email to follow new studies for SOLID NEOPLASMS WITH NTRK FUSIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Spanish doctors review rare cancer Drug's Real-World impact

Knowledge-focused Completed

This study looked back at medical records to learn how 20 Spanish cancer patients with a specific, rare genetic change (NTRK fusion) responded to the drug larotrectinib. The patients received the drug through a special access program before it was commercially available. The goal…

Matched conditions: SOLID NEOPLASMS WITH NTRK FUSIONS

Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Knowledge-focused

Last updated Mar 18, 2026 14:40 UTC

SOLID NEOPLASMS WITH NTRK FUSIONS

Get alerted when new SOLID NEOPLASMS WITH NTRK FUSIONS trials appear

Spanish doctors review rare cancer Drug's Real-World impact